LSU Health Shreveport / Feist-Weiller Cancer Center is a strategic partner with MD Anderson and the Cancer Focus Fund LP working to advance promising cancer therapies.

“BRAID is more than just a conference, it’s a vibrant ecosystem of ideas fostering innovation among students, scientists and clinicians,” said Wayne Nix, chief innovation officer at LSUHS. “We celebrate the great minds of academia and industry brought together for a collaborative effort from all of our partners."

KTBS3 - The family-friendly event hosted by the LSUHS Center for Cardiovascular Diseases and Science helps participants understand healthier lifestyle habits through educational activities about heart health, and engagement with LSUHS healthcare professionals.

Louisiana Economic Development - LSU Health Shreveport scientists have discovered a promising new treatment for prostate cancer and developed a playbook detailing how to track viral variants in underserved areas.

KSLA12 - Heart Health Day is a free community heart health event to be held Saturday, Oct. 14 from 9 am to 12 pm at Ochsner LSU Health - St. Mary Medical Center, located at 915 Margaret Place. Attendees can expect free health screenings, group exercise activities, nutrition guidance, goodie bags, and more.

Feist-Weiller Cancer Center, a Center of Excellence in Cancer Research, Treatment and Education at LSUHS and Loxo@Lilly, the oncology unit of Eli Lilly and Company, recently launched a new research collaboration that will provide next-generation sequencing (NGS) access to underserved cancer patients in the northern Louisiana region.

Researchers from academic institutions in Louisiana, Mississippi and Georgia have partnered to publish a playbook detailing their model developed for establishing collaborative, community-centered infectious diseases surveillance programs committed to improving equity in genomic sequencing.

KSLA 12 - Funded by the NIH and American Heart Association, the Center for Cardiovascular Diseases and Science presented the CURIOUS Poster Session, the finale to the summer research programs at LSUHS this year.

318 Forum - LSUHS Neurology Professors, Dr. Elizabeth Disbrow and Dr. Roger Kelly, share information on treatments for Alzheimer's disease, including the new FDA approved treatment for early stage patients.

Since July 2021, the group has received grants funded for a total of $5.5 Million and had papers published in or accepted to several prestigious journals.

318 Forum - Dr. Elizabeth Disbrow, Director of the Center for Brain Health, shares how medical advancements in Alzheimer's research are being made through clinical trials and current opportunities at LSUHS.

KSLA12 - Dr. Elizabeth Disbrow, Director of the Center for Brain Health at LSUHS, talks about the signs of Parkinson's Disease and the opportunity for African-Americans to participate in a new study at the Center.

The Center for Emerging Viral Threats at LSUHS recently sequenced the first instances in Louisiana of the XBB.1.16 and XBB.1.9.1 variants. "Detecting these very recently emerging variants demonstrates the robustness of our efforts,” said Krista Queen, PhD, Director of Viral Genomics and Surveillance.

318 Forum - Towanno Alexander, RT, Project Manager for Partners In Wellness at LSUHS, shares information on how LSUHS is supporting cancer prevention and treatment in our community and abroad. "Everyone agrees that early detection and prevention are key in cancer survival."

KSLA12 - LSU Health Shreveport is excited to host its second annual cancer survivorship walkathon on Saturday, May 13.The walkathon was started after medical student, Tanner Ward, saw a need in the community to celebrate their friends and loved ones.